Answer
Rarely, concurrent lithium and HALDOL Decanoate use has been associated with encephalopathy, extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome, acute brain syndrome and coma; most symptoms were reversible, and therapy must stop immediately if these occur.
Sources for this answer
- HALDOL Decanoate 50 mg/ml solution for injection and HALDOL Decanoate 100 mg/ml solution for injectionEssential Pharma Ltd (Malta) · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked